Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Strategy Officer
-
Issuer Symbol
-
ANTX on Nasdaq
Stephen David Prior - trading volume in the past year for AN2 Therapeutics, Inc.
Holdings reported by Stephen David Prior for AN2 Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
59,086 |
$59,795 |
$1.01 |
06 Jan 2026 |
Direct |
|
|
| Stock Option (right to buy) |
56,000 |
|
|
26 Feb 2025 |
Direct |
Common Stock |
|
Transactions reported by Stephen David Prior for AN2 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.